Search results
Results from the WOW.Com Content Network
Wen Ken Group consists of the headquarter, Wen Ken Drug Co. Pte Ltd in Singapore, and its subsidiary companies located in both Singapore and Malaysia respectively. The subsidiary companies practically function as independent business components and each specialises in one of the following fields: (i) Brands & Products, (ii) Manufacturing, (iii ...
Yuchengco was the Chairman of the Yuchengco Group of Companies, and concurrently the Chairman of the Board of MICO Equities, Inc. (holding company of the Malayan Group of Insurance Companies); Pan Malayan Management and Investment Corporation; Mapúa Institute of Technology; Nippon Life Insurance Company; and the Rizal Commercial Banking Corporation.
He holds the Vice Chairmanship of the Pan Malayan Management and Investment Corporation (PMMIC), the controlling shareholder of House of Investments, RCBC, and other leading firms. Tan is the former President and CEO of the Yuchengco-owned publicly-listed bank, Rizal Commercial Banking Corporation.
P. Veerasenan was a notable labour unionist from Singapore.He was once the President of Standing Committee of Singapore General Labour Union (SGLU) as well as the vice-president of Singapore Federation of Trade Unions(SFTU).
Pty Ltd Azerbaijan: məhdud məsuliyyətli cəmiyyət MMC Bangladesh: private company limited by shares: Pvt. Ltd. (OPC) India Nepal Bosnia and Herzegovina: društvo s ograničenom odgovornošću: d.o.o. [b] Croatia Montenegro Serbia North Macedonia: društvo so ograničena odgovornost Slovenia: Družba z omejeno odgovornostjo Brazil
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. [1] One subsidiary, China Pharmaceutical Group Co., Ltd (China Pharma) is based in Hong Kong.
In February 2015, AMRI acquired SSCI based in West Lafayette, Indiana. SSCI was founded in 1991, providing comprehensive cGMP solid state chemistry research and analytical services to the pharmaceutical industry. Servicing more than 250 customers a year. [25] [26] In July 2015, the company acquired Gadea Pharmaceutical group for $174 million. [27]
Brenntag's main operations include food, pharmaceuticals, cosmetics, oil and gas, and water purification. [5] Brenntag's product catalog includes more than 10,000 items ranging from acids, bases, and solvents to substances for the food, cosmetics, feed and pharmaceutical industries.